Our Team
The Null Hypothesis Initiative brings together biomedical researchers, publishing leaders, and advocates for research transparency.
Our operations team consists of experienced biomedical researchers and clinical innovators who lead the development and scientific oversight of the Null Compass platform.
Dr. Hugo Stephenson
Project Lead & Co-Founder
Clinical trials innovator and clinician with over 20 years of experience in medical research. Champions the publication of negative results to strengthen scientific integrity.
A/Prof. Sandra Petty
Co-Founder & Scientific Director
Neurologist, medical educator, clinical and lab researcher specializing in epilepsy and bone medicine. Strong advocate for research integrity and evidence-based medicine.
Dr. Emma Burrows
Communications
Neuroscientist who cares about making clinical research more accessible and patient-focused, as well as building communities that support research innovation. Passionate about making science understandable to all.
Our Scientific Advisory Committee includes distinguished medical professionals and researchers who guide our strategic direction and ensure scientific rigor.
Prof. Howard Bauchner
Chair, Scientific Advisory Committee
Former Editor-in-Chief of JAMA and leading voice in medical publishing and research transparency. Brings decades of editorial leadership and commitment to ensuring high-quality negative findings are visible and valued.
Dr. Luis-Gabriel Cuervo, MD
Scientific Advisor
PAHO/WHO's Senior Advisor on Research for Health and global leader in evidence-based policy. Clinical epidemiologist championing efforts to reduce research waste and increase value of health science.
Prof. Ana Marušić, MD PhD
Scientific Advisor
Professor at University of Split and Co-Editor-in-Chief of Journal of Global Health. Global leader in research integrity who has shaped clinical trial registration policies and serves on COPE, EQUATOR, and Cochrane leadership teams.
Julie Wood
Scientific Advisor
Senior Director at Vivli leading global data sharing operations. Former Cochrane and Oxfam communications leader who co-chairs NIH's GREI initiative and advocates for open, accessible research infrastructures.
Dr. David Tovey, MBBS
Scientific Advisor
Co-Editor-in-Chief of the Journal of Clinical Epidemiology. Former Cochrane Library Editor-in-Chief and BMJ Editorial Director.
Our Board of Directors provides governance oversight and strategic direction for the Null Hypothesis Initiative.
Dr. Annalisa Jenkins, MBBS FRCP
Board Member
Biotech leader and rare disease advocate. Former Royal Navy medical officer who has led global clinical and regulatory programs at Dimension Therapeutics, Merck Serono, and BMS.
Eric Jaffe, AIA, NCARB
Board Member
Global leader in research-focused architecture directing science and technology design projects at HDR. His portfolio spans academic and pharma innovation spaces for institutions like Duke and Novartis.
Carrie Delente, BFA
Board Member
Founder of Enforme Interactive, shaping digital strategy for academic journals and scientific organizations for over 25 years. Leads large-scale platforms supporting physician education and research dissemination.
Dr. Robert A. Gross, MD PhD
Board Member
Neurologist and former Editor-in-Chief of Neurology®. Thought leader in neuropharmacology and epilepsy with prior roles at Harvard, Michigan, and Rochester. Widely respected for advancing rigorous editorial standards.
Dr. David Tovey, MBBS
Board Member
Co-Editor-in-Chief of the Journal of Clinical Epidemiology. Former Cochrane Library Editor-in-Chief and BMJ Editorial Director.